Opella Healthcare Group SAS clinical trials
Formerly part of Sanofi, Apr 30, 2025 · source ↗
The registry lists 3 studies whose lead sponsor is Opella Healthcare Group SAS. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 12, 2025.
- 3studies on the registry
- 0open to participants now
Before and after it left Sanofi
- First submitted before Opella Healthcare Group SAS left Sanofi
- 3
- First submitted after Opella Healthcare Group SAS left Sanofi
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Opella Healthcare Group SAS’ studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- fexofenadine1 in phase 30 open · 1
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3100%
Over the years
- 23
- 224
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Opella Healthcare Group SAS, a Sanofi Company3 studies
Something wrong with this grouping? Tell us on the Sanofi page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Sanofi studies →
- Bioavailability Study of Fexofenadine HCl New Formulation TabletCompletedNCT06284902Phase 1
Sponsor listed in the registry: Opella Healthcare Group SAS, a Sanofi Company · First submitted before Opella Healthcare Group SAS left Sanofi
- Bioavailability Study of Magne-B6 New FormulationCompletedNCT06386211Phase 1
Sponsor listed in the registry: Opella Healthcare Group SAS, a Sanofi Company · First submitted before Opella Healthcare Group SAS left Sanofi
- A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic RhinitisCompletedNCT05692154Phase 3
Sponsor listed in the registry: Opella Healthcare Group SAS, a Sanofi Company · First submitted before Opella Healthcare Group SAS left Sanofi